1. Home
  2. UTF vs IDYA Comparison

UTF vs IDYA Comparison

Compare UTF & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cohen & Steers Infrastructure Fund Inc

UTF

Cohen & Steers Infrastructure Fund Inc

HOLD

Current Price

$27.00

Market Cap

3.1B

Sector

Finance

ML Signal

HOLD

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$31.38

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UTF
IDYA
Founded
N/A
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
2.6B
IPO Year
2004
2019

Fundamental Metrics

Financial Performance
Metric
UTF
IDYA
Price
$27.00
$31.38
Analyst Decision
Strong Buy
Analyst Count
0
16
Target Price
N/A
$52.86
AVG Volume (30 Days)
290.5K
1.1M
Earning Date
01-01-0001
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
61.90
EPS
N/A
N/A
Revenue
N/A
$218,710,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$201.05
P/E Ratio
N/A
N/A
Revenue Growth
N/A
3024.43
52 Week Low
$23.42
$20.50
52 Week High
$27.65
$39.28

Technical Indicators

Market Signals
Indicator
UTF
IDYA
Relative Strength Index (RSI) 48.91 58.29
Support Level $26.54 $29.51
Resistance Level $27.23 $31.51
Average True Range (ATR) 0.33 1.66
MACD -0.00 0.33
Stochastic Oscillator 36.44 79.93

Price Performance

Historical Comparison
UTF
IDYA

About UTF Cohen & Steers Infrastructure Fund Inc

Cohen & Steers Infrastructure Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is total return with an emphasis on income. Under normal market conditions, the fund invests the majority of its managed assets in securities issued by infrastructure companies, which consist of utilities, pipelines, toll roads, airports, railroads, ports, telecommunications companies, and other infrastructure companies.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: